![Shaheen Tejani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shaheen Tejani
Directeur/Bestuurslid bij Novation Pharmaceuticals, Inc.
Profiel
Shaheen Tejani is currently a Director at Vancouver General Hospital, Novation Pharmaceuticals, Inc., and University of British Columbia Hospital Foundation.
Previously, she held Principal positions at Vancouver General Hospital, University of British Columbia Hospital Foundation, and Waterstreet Technology Group.
Actieve functies van Shaheen Tejani
Bedrijven | Functie | Begin |
---|---|---|
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Directeur/Bestuurslid | - |
Vancouver General Hospital | Directeur/Bestuurslid | - |
University of British Columbia Hospital Foundation | Directeur/Bestuurslid | - |
Eerdere bekende functies van Shaheen Tejani
Bedrijven | Functie | Einde |
---|---|---|
Vancouver General Hospital | Corporate Officer/Principal | - |
University of British Columbia Hospital Foundation | Corporate Officer/Principal | - |
Waterstreet Technology Group | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Vancouver General Hospital | |
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Health Services |
University of British Columbia Hospital Foundation | |
Waterstreet Technology Group |